{
  "case_id": "case_0018",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 39.18,
    "sex": "Male",
    "genderIdentity": "Cisgender Female",
    "ancestry": "East Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, Compressive Optic Neuropathy and Retinal Detachment.\n\nOther possible differentials:\n- SLE, Neurosyphilis and Bartonella.\n- Also feasible but of low probability: TB, Beh\u00e7et's, Lyme, Lymphoma, Vasculitis, Sjogren's and Leber's Hereditary Optic Neuropathy.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Non-arteritic anterior ischaemic optic neuropathy (atypical for age, usually > 50)\n- Toxic or nutritional optic neuropathy (atypical for strictly unilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Demyelinating optic neuritis associated with multiple sclerosis",
          "Myelin oligodendrocyte glycoprotein (MOG) antibody\u2013associated optic neuritis",
          "Neuromyelitis optica spectrum disorder\u2013related optic neuritis",
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Compressive optic neuropathy of the left optic nerve (for example optic nerve sheath meningioma or parasellar mass)",
          "Inflammatory or infiltrative optic neuropathy (for example sarcoidosis or systemic vasculitis)",
          "Toxic or nutritional optic neuropathy",
          "Primary retinal pathology causing unilateral visual loss (for example central retinal artery occlusion or retinal detachment)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Compressive_Optic_Neuropathy",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "MOGAD",
          "Retinal_Detachment"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "Bartonella_Henselae",
          "Idiopathic_Optic_Neuritis",
          "Behcet_Disease",
          "Infection_Lyme",
          "Syphilis",
          "CNS_Lymphoma",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "Autoimmune_Myelitis_SLE",
          "Optic_Neuropathy_Nonspecific",
          "Leber_Hereditary_Optic_Neuropathy"
        ],
        "missing_common_names": [
          "Bartonella",
          "Neurosyphilis",
          "SLE"
        ],
        "missing_low_prob_names": [
          "TB",
          "Beh\u00e7et's",
          "Lyme",
          "Lymphoma",
          "Vasculitis",
          "Sjogren's",
          "Leber's Hereditary Optic Neuropathy"
        ],
        "additional_diagnoses": [
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Toxic or nutritional optic neuropathy"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 2,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 18,
        "lesion_ddx_matched_count": 6,
        "lesion_ddx_missed_common_count": 3,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.3333333333333333
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, ENA, ACE, HIV, ANCA, anti-AQP4, syphilis, ESR.\n- Could also consider testing: anti-dsDNA, bartonella, TB, lyme, CSF (flow cytometry and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "Urgent ophthalmology assessment with dilated fundus examination",
          "Visual acuity testing with pinhole correction",
          "Color vision testing using Ishihara plates",
          "Automated visual field testing (perimetry)",
          "Optical coherence tomography of the retinal nerve fiber layer and macula",
          "MRI of brain and orbits with gadolinium contrast including dedicated optic nerve sequences",
          "Visual evoked potentials",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Serum vitamin B12",
          "Serum folate",
          "Serum aquaporin-4 IgG antibodies",
          "Serum MOG-IgG antibodies",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Angiotensin-converting enzyme level",
          "Syphilis serology",
          "HIV 1 and 2 serology",
          "Antineutrophil cytoplasmic antibodies",
          "Lumbar puncture with CSF cell count, protein, and glucose",
          "CSF oligoclonal bands and IgG index"
        ],
        "all_identified_ft_keys": [
          "MOG_Antibodies",
          "CRP",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "CSF_General",
          "Visual Acuity",
          "FBC",
          "ANA",
          "OCT",
          "Folate",
          "Colour Vision",
          "Ophthalmology Assessment",
          "HIV_Test",
          "ANCA",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Bartonella_Serology",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "Bartonella_Serology",
          "TB_Screen",
          "CSF_Cytology",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 10,
        "ddx_tests_coverage_percentage": 0.625
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3 days",
            "timing": "Start Now",
            "reasons": [
              "Typical inflammatory optic neuritis is the leading diagnosis and high-dose steroids shorten the duration of visual symptoms",
              "Early therapy may limit irreversible demyelinating damage to the optic nerve",
              "Can be initiated promptly after urgent MRI excludes compressive or infectious lesions"
            ]
          },
          {
            "treatment": "Oral prednisolone taper for 11\u201314 days following intravenous steroids",
            "timing": "Delay",
            "reasons": [
              "Introduced after completing intravenous methylprednisolone to reduce risk of rebound inflammation",
              "Oral steroids alone without a preceding high-dose IV course are not recommended in demyelinating optic neuritis"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for multiple sclerosis if diagnostic criteria are met",
            "timing": "Delay",
            "reasons": [
              "Requires MRI and CSF evidence of dissemination in time and space before initiation",
              "Choice of agent depends on individual risk profile and specialist neuroimmunology input",
              "Not required for acute visual recovery at the initial presentation"
            ]
          },
          {
            "treatment": "Therapeutic plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserved for severe optic neuritis or cases that fail to improve after high-dose corticosteroids",
              "Particularly important if neuromyelitis optica spectrum disorder or MOG-antibody disease is confirmed or strongly suspected"
            ]
          },
          {
            "treatment": "Long-term immunosuppression for neuromyelitis optica spectrum disorder such as rituximab, inebilizumab, or eculizumab",
            "timing": "Delay",
            "reasons": [
              "Instituted only if serology or clinical criteria confirm neuromyelitis optica spectrum disorder",
              "Requires chronic monitoring for efficacy and adverse effects and is not started before a definite diagnosis"
            ]
          },
          {
            "treatment": "Simple analgesia such as paracetamol or non-steroidal anti-inflammatory drugs",
            "timing": "Start Now",
            "reasons": [
              "Periocular pain, especially with eye movements, is common in optic neuritis and can be distressing",
              "Safe symptomatic treatment that improves comfort while definitive investigations and therapies proceed"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastroprotection while receiving high-dose corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "Reduces risk of steroid-associated gastrointestinal irritation or bleeding",
              "Particularly important if non-steroidal anti-inflammatory drugs are also used for analgesia"
            ]
          },
          {
            "treatment": "Referral for visual rehabilitation and occupational therapy if visual recovery is incomplete",
            "timing": "Delay",
            "reasons": [
              "Need for rehabilitation can only be assessed after the course of visual recovery is known",
              "Provides strategies and low-vision aids to maximise independence if a permanent visual deficit remains"
            ]
          },
          {
            "treatment": "Antiplatelet therapy and aggressive vascular risk factor modification if ischaemic optic neuropathy is diagnosed",
            "timing": "Delay",
            "reasons": [
              "Ischaemic optic neuropathy is less likely in this young patient but must be treated appropriately if confirmed",
              "Antiplatelet therapy carries bleeding risk and should be targeted to patients with proven vascular aetiology"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3 days",
            "timing": "Start Now",
            "reasons": [
              "Typical inflammatory optic neuritis is the leading diagnosis and high-dose steroids shorten the duration of visual symptoms",
              "Early therapy may limit irreversible demyelinating damage to the optic nerve",
              "Can be initiated promptly after urgent MRI excludes compressive or infectious lesions"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for multiple sclerosis if diagnostic criteria are met",
            "timing": "Delay",
            "reasons": [
              "Requires MRI and CSF evidence of dissemination in time and space before initiation",
              "Choice of agent depends on individual risk profile and specialist neuroimmunology input",
              "Not required for acute visual recovery at the initial presentation"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        }
      }
    }
  }
}